1. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2021) Authors: Han, Joseph K; Bachert, Claus; Fokkens, Wytske; Desrosiers, Martin; Wagenmann, Martin; Lee, Stella E; Smith, Steven G; Martin, Neil; Mayer, Bhabita; Yancey, Steven W; Sousa, Ana R; Chan, Robert; Hopkins, Claire; Ahlström Emanuelsson, Cecilia; Ardusso, Ledit; Armstrong, Michael; Bardin, Philip; Ba... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Outbreaks in care homes may lead to substantial disease burden if not mitigated. (31st May 2021) Authors: Hall, Ian; Lewkowicz, Hugo; Webb, Luke; House, Thomas; Pellis, Lorenzo; Sedgwick, James; Gent, Nick Journal: Philosophical transactions Issue: Volume 376:Number 1829(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗